Skip to content

XOMA Corporation XOMA Interest coverage

Interest coverage at other companies

Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
16.9×+11.3×
Royalty Pharma logo
Royalty PharmaRPRX
4.7×-3.0×
Theravance Biopharma logo
Theravance BiopharmaTBPH
-1.5×-0.7×
Innoviva, Inc. logo
Innoviva, Inc.INVA
9.2×+0.5×
Zymeworks logo
ZymeworksZYME
-9×+3.2×
ALN
Alnylam PharmaceuticalsALNY
3.4×+2.9×

Other financials

Income statement

See full
Revenue$12.3M-22.6%
Operating income-$480.0K-108%
Net income$4.5M+88.6%
EPS (diluted)$0.17+183%

Balance sheet

See full
Cash & equivalents$85.6M-5.2%
Total debt$124.7M+9.0%
Total equity$92.9M+9.7%
Total assets$271.9M+27.8%

Cash flow

See full
Operating cash flow$6.1M+178%
CapEx$3.0K-29.4%
Free cash flow-$2.9M+36.0%

Valuation

See full
Market cap$746.04M+159%
Enterprise value$785.17M+152%
P/E22.1×
P/S15.4×+8.7×

Profitability

See full
Operating margin10.2%+5.5pp
Net margin69.6%+64.0pp
FCF margin-320%-118pp

Returns & leverage

See full
Return on equity38.1%+35.2pp
Debt / equity1.3×0.0×
Current ratio3.6×-2.0×

Where this comes from

Calculated from XOMA Corporation’s reported figures.

Based on trailing twelve months.

The official record: XOMA Corporation’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about XOMA Corporation's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is XOMA Corporation's interest coverage?
XOMA Corporation (XOMA) reported interest coverage of 0.4× in Q1 2026.
How has XOMA Corporation's interest coverage changed year-over-year?
XOMA Corporation's interest coverage increased by 119.6% year-over-year, from -2× to 0.4×.
What is the long-term trend for XOMA Corporation's interest coverage?
Over 3 years (2020 to 2025), XOMA Corporation's interest coverage has grown at a -49.4% compound annual growth rate (CAGR), from 6.7× to 0.9×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.